Professor John Greenwood is the Director of the Baker Heart and Diabetes Institute, Melbourne, Australia and Adjunct/Visiting Professor at Melbourne University, Monash University, and also the University of Leeds, UK. As a consultant cardiologist for 20 years, he has specialised in coronary intervention and cardiovascular magnetic resonance (CMR) imaging. Professor Greenwood underwent his clinical and academic training in Leeds, UK, and in addition underwent specialist training in coronary intervention in Toulouse, France and Cardiovascular Magnetic Resonance (CMR) imaging at the Royal Brompton Hospital, London. His main focus of research has been the diagnosis and treatment of stable and unstable coronary artery disease. In terms of diagnostics, this particularly involved the use of CMR in terms of pulse sequence development and validation through large scale clinical trials. In terms of therapeutics, he has collaborated on a number of major multi-centre clinical trials designed to improve outcomes in patients undergoing primary PCI for acute ST elevation myocardial infarction or stable complex coronary artery disease. In particular, early phase clinical trials of drugs and devices to reduce infarct size in the setting of acute myocardial infarction. He is the immediate Past-President of the British Cardiovascular Society (BCS; 2021-2024) and a member of Council of The Royal College of Physicians, London. He was elected to the Board of BSCMR (British Society of Cardiovascular MR) in 2008, and became BSCMR President (2018-2020). He is past-Chair of the SCMR clinical trials committee (2015-2017) and member of the SCMR scientific programme committee (2016-2019). He was the SCMR representative on the 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain. He was a winner of the SCMR Gold Medal in 2023 and Associate Editor of JCMR (2017-2023). He is a member of the ESC Cardio-policy group (2022-2024), ESC Advocacy Committee (2021-current) and a past member of the Assembly of International Governors of the ACC (2021-2024). He has supervised/co-supervised to completion ~30 MD/PhD students and has ~400 peer-reviewed publications, including many in NEJM, Lancet, JAMA, Circulation, JACC and EHJ.

Dr Harsh Thakkar is currently based in Melbourne, and is a PhD candidate and Interventional fellow at the Victorian Heart Hospital. He has a keen interest in research and his interests in cardiology include heart failure, cardiac imaging and interventional cardiology. He has been actively involved in research since 2013 and is currently growing his experience in the field. He has previously presented at national and international meetings including the CSANZ, TCT, AICT-Asia PCR and the American College of Cardiology scientific meetings.

Ben Cailes is a Cardiologist and PhD fellow through the Austin Hospital in Melbourne and the University of Melbourne. He is a current recipient of both National Health and Medical Research Council (NHMRC) and National Heart Foundation (NHF) post-graduate scholarships. He has previously received the Royal Australasian College of Physicians (RACP) Trainee Research Award for Excellence in 2019 and was a co-author of research awarded runner-up in the CSANZ Imaging Prize in 2018. Ben’s PhD is exploring cirrhotic cardiomyopathy in patients with end-stage liver failure, with a focus on improving the diagnostic criteria for this poorly-defined condition and assessing novel non-invasive investigations that can be used to minimise cardiac perioperative risk in this vulnerable patient group.

Gavin is a cardiology registrar from Perth, Western Australia who is currently undertaking a Masters in Research in the field of cardiometabolic health. He is passionate about cardiology and particularly interested in cardiac imaging, namely cardiac CT.

Dr Paratz is an academic cardiologist from St Vincent’s Institute of Medical Research. She completed her PhD in 2023 in the field of cardiac arrest and undertook a cardiac imaging fellowship in 2023. Her research interests include cardiac arrest, big data and aviation cardiology.

Jae K. Oh, M.D., is a consultant in the Department of Cardiovascular Medicine at Mayo Clinic in Rochester. He currently serves as director of the Echocardiography Core Laboratory. He is also director of the Pericardial Clinic and co-director of Integrated Cardiac Imaging. Dr. Oh is recognized with the distinction of a named professorship, the Samsung Professorship in Cardiovascular Diseases. He has been working with the Samsung Medical Center for Samsung-Mayo Collaboration and is the Founding General Director of Heart Vascular Stroke Institute at Samsung Hospital in Seoul, Korea. Dr. Oh earned his B.S. degree in biochemistry with honors at the University of Pennsylvania, and his M.D. degree at Pennsylvania State University. He completed a residency in internal medicine, with an outstanding achievement award, and a fellowship in cardiovascular diseases, both at Mayo Clinic College of Medicine. Dr. Oh has research interest in all aspects of echocardiography and its use in clinical trials as well as in clinical diagnoses. His research focuses on diastolic function, heart failure related to diastolic dysfunction, valvular heart diseases, pericardial diseases, and artificial intelligence using ECG and Echocardiography. He has established noninvasive Mayo Clinic diagnostic criteria for constrictive pericarditis and the concept of transient constriction. Dr. Oh is also passionate about pursuing multimodality imaging in cardiovascular diseases. He is frequently invited to give presentations on his research both domestically and internationally and has authored over 500 manuscripts. He has published 4 editions of “The Echo Manual” which has become a standard textbook for echocardiography. In recognition of his work, Dr. Oh has received many awards and honors, including the Cardiovascular Teacher of the Year for several years and Most Outstanding Mentor Award in Internal Medicine, conferred by Mayo Clinic, and named Lectureships (the William Gaash Lecture, Euro Echo Lecture, Edler Lecture at the EACVI, Echo Seoul, HB Callejo 1st Memorial Lecture in Philippine) Dr. Oh has received the Lifetime Achievement Award from the European Society of Cardiology Myocardial-Pericardial working group and the 10th Lifetime Achievement Award from the American Society of Echocardiography in June of 2019. In addition to his research activities, Dr. Oh is active in education and mentoring. He holds full faculty privileges in Clinical and Translational Science at Mayo Graduate School, Mayo Clinic College of Medicine. He has mentored more than 70 physicians at Mayo and around the world. Dr. Oh holds memberships with numerous professional organizations, including the fellowship of the American College of Cardiology, the American Heart Association, the American Society of Echocardiography, and the European Society of Cardiology. He currently serves as president of the Asian-Pacific Association of Echocardiography.

Athena Poppas, MD, FACC, is the Director of Lifespan Cardiovascular Institute, at Rhode Island, Miriam, and Newport Hospitals, and is Chief of the Cardiology Division and Professor of Medicine at the Warren Alpert Medical School of Brown University. Dr Poppas received a Bachelor of Science degree from Brown University and a Doctor of Medicine from the University of Wisconsin School of Medicine. She completed her residency in Internal Medicine at University of Wisconsin Hospital and Clinics and fellowship in Cardiovascular Medicine at University of Chicago Hospital. Her clinical and research areas of focus are in echocardiography and in treating patients with valvular heart disease and heart disease during pregnancy. She was named a Top Doctor by Rhode Island Monthly magazine and has received numerous teaching awards at Brown University and Rhode Island Hospital. Prior to becoming ACC president, Poppas held numerous leadership roles within the College including chair of the Women in Cardiology Section, chair of the ACC Annual Scientific Session in 2015- 2016, chair of the ACC Sections Steering Committee and chair of the ACC Governance Committee. She also served on the ACC Board of Governors as governor and president of the ACC Rhode Island Chapter, as well as on the ACC Board of Trustees. Dr Poppas is also a Fellow of the American Society of Echocardiography, where she has served on committees, including ethics, nominating and scientific programs. She has also worked with the American Heart Association and the European Society of Cardiology, among other organizations.

Professor Michelle Williams is a Professor of Cardiovascular Imaging at the University of Edinburgh and Honorary Consultant Radiologist at NHS Lothian. She is Associate Director of the British Heart Foundation Data Science Centre and the Imaging theme lead. Her research centers around multi-modality non-invasive imaging of the heart and blood vessels, including using machine learning and other advanced analytic techniques. She is president of the British Society of Cardiovascular Imaging, member of the executive community of the European Society of Cardiovascular Radiology, member of the Board of Directors of the SCCT, and chair of the SCCT education committee.